Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
The Federal Court dismissed Apotex Inc.'s appeal from a prothonotary's order granting the Information Commissioner of Canada leave to be added as a respondent to Apotex's applications for judicial review.
Miller Thomson LLP
With the amendments to the Criminal Code, physicians and nurse practitioners may now legally provide MAID to eligible individuals.
Howie, Sacks & Henry
Questioning a medical professional when something does not seem right can be an intimidating thought.
Norton Rose Fulbright Canada LLP
Bayer Inc. markets moxifloxacin in Canada under the name AVELOX I.V.TM for use in the treatment of bacterial infection.
Norton Rose Fulbright Canada LLP
This decision is an appeal from a judgement of the Federal Court declining to vary its decision awarding damages to Apotex under section 8 of the Regulations.
Howie, Sacks & Henry
John Wooden said that "It's the details that are vital. Little things make big things happen." In health care, details are literally vital because they impact a patient's life.
Norton Rose Fulbright Canada LLP
The proliferation of medical marijuana dispensaries in cities such as Vancouver and Toronto has prompted city councillors to crack down—albeit in different ways—on these illegal businesses.
Gowling WLG
In my earlier article Bill C-17: modernizing the Food and Drugs Act but at what cost?1, I described the potential implications of the Protecting Canadians from Unsafe Drugs Act (also known as Vanessa's Law).
Torys LLP
The Discussion Paper hints that the PMPRB may propose a number of reforms to the Guidelines which would likely lower the maximum allowable prices of many patented medicines at and after introduction.
Norton Rose Fulbright Canada LLP
On June 24th, the Patented Medicine Prices Review Board (PMPRB) published "PMPRB Guidelines Modernization Discussion Paper" (Discussion Paper).
Norton Rose Fulbright Canada LLP
The College of Pharmacists of British Columbia (CPBC) is the regulatory body responsible for licensing and registering pharmacists, pharmacies and pharmacy technicians in British Columbia.
Moldofsky Professional Corporation
The new law provides exemptions to the Criminal Code to permit for medical assistance in dying, previously a crime in Canada.
Norton Rose Fulbright Canada LLP
In January 2015, the Patented Medicine Prices Review Board commenced a proceeding against Alexion Pharmaceuticals Inc. alleging it had sold its drug SOLIRIS® (eculizumab) at an excessive price.
Norton Rose Fulbright Canada LLP
Bristol-Myers Squibb Canada Co. (BMS Canada) markets atazanavir bisulfate in Canada under the name REYATAZ® for the treatment of HIV.
McMillan LLP
The Vermont Genetically Engineered Food Labeling Act ("Vermont Act") was passed on May 8, 2014 and was the first act of its kind to come into force in North America, taking effect on July 1, 2016.
Norton Rose Fulbright Canada LLP
The Federal Court of Appeal has dismissed two appeals arising out of two consecutive motions brought by Teva Canada Limited for leave to amend its statement of claim.
Lerners
Yola Ventresca, Sarah Martens and Natalie Carrothers review the Divisional Court decision in College of Nurses of Ontario v Mark Dumchin and the unanswered questions the decision raises.
McInnes Cooper
Healthcare practitioners in Newfoundland and Labrador cannot claim privilege over "quality assurance" information when it comes to sharing it with professional regulatory bodies.
Norton Rose Fulbright Canada LLP
Apotex Inc., Apotex Pharmachem India Pvt Ltd. (APIPL) and Apotex Research Private Limited (ARPL) (collectively, Apotex) sought judicial review of a decision of the Minister of Health (Minister) to vary the terms and conditions of the Drug Establishment Licence ..
Gowling WLG
Now that the UK has voted to leave the European Union, many industries and organisations are faced with uncertainty and the possibility of change to everything from supply chains to export and manufacturing.
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Canada LLP
In January 2015, the Patented Medicine Prices Review Board commenced a proceeding against Alexion Pharmaceuticals Inc. alleging it had sold its drug SOLIRIS® (eculizumab) at an excessive price.
Norton Rose Fulbright Canada LLP
The proliferation of medical marijuana dispensaries in cities such as Vancouver and Toronto has prompted city councillors to crack down—albeit in different ways—on these illegal businesses.
Norton Rose Fulbright Canada LLP
Bristol-Myers Squibb Canada Co. (BMS Canada) markets atazanavir bisulfate in Canada under the name REYATAZ® for the treatment of HIV.
Osler, Hoskin & Harcourt LLP
The value of start-up companies often hinges on their intellectual property and on the commercialization of novel technology, often in partnerships with established players.
Borden Ladner Gervais LLP
Celltrion brought a motion pursuant to s. 6(5)(b) of the Patented Medicines (Notice of Compliance) Regulation (the NOC Regulations) to have the application dismissed.
Norton Rose Fulbright Canada LLP
The Federal Court of Appeal has dismissed two appeals arising out of two consecutive motions brought by Teva Canada Limited for leave to amend its statement of claim.
Bull, Housser & Tupper LLP
Two recent decisions highlight unexpected liabilities that can arise for employers regarding health benefits plans.
Gowling WLG
Now that the UK has voted to leave the European Union, many industries and organisations are faced with uncertainty and the possibility of change to everything from supply chains to export and manufacturing.
McInnes Cooper
Healthcare practitioners in Newfoundland and Labrador cannot claim privilege over "quality assurance" information when it comes to sharing it with professional regulatory bodies.
Norton Rose Fulbright Canada LLP
The Federal Court granted a motion to dismiss an application under s. 6(5)(b) of the PM(NOC) Regulations on the basis that the second person would not infringe the patent.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with